Synergistic Vaccine System for Necrotic Enteritis Prevention in Poultry
Legal Citation
Summary of the Inventive Concept
A comprehensive system integrating a novel vaccine, blockchain, IoT, AI, and plant-based delivery to prevent necrotic enteritis in poultry, providing real-time monitoring, data-driven decision making, and optimized vaccine distribution.
Background and Problem Solved
The original patent addressed the limitations of existing vaccines for necrotic enteritis in poultry, but lacked a comprehensive system for prevention and control. This new inventive concept integrates distinct technologies to create a powerful system that overcomes the limitations of the original patent.
Detailed Description of the Inventive Concept
The system comprises a blockchain-based vaccine tracking module, a cloud-based data analytics platform, and a machine learning algorithm for predicting disease outbreaks. The vaccine is administered orally through a plant-based delivery system comprising a fusion protein combining immunogenic and non-toxic components of alpha-toxin and NetB. IoT sensors track environmental conditions, and AI-powered image recognition detects disease symptoms. The vaccine is delivered through a drone-based system, and the blockchain-based supply chain management system optimizes vaccine distribution.
Novelty and Inventive Step
The new claims introduce a synergistic combination of technologies, including blockchain, IoT, AI, and plant-based delivery, which are not present in the original patent. The inventive step lies in the integration of these technologies to create a comprehensive system for necrotic enteritis prevention and control.
Alternative Embodiments and Variations
Alternative embodiments may include using different types of sensors, machine learning algorithms, or blockchain platforms. Variations may include adapting the system for use in different poultry production settings or integrating additional technologies, such as robotics or nanotechnology.
Potential Commercial Applications and Market
The synergistic vaccine system has significant commercial potential in the poultry industry, with potential applications in disease prevention and control, supply chain management, and data-driven decision making. The target market includes poultry producers, veterinarians, and animal health companies.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K39/08 |
| A | A61 | A61P31/04 |
| C | C12 | C12N15/74 |
| C | C12 | C12N15/8258 |
| A | A61 | A61K2039/552 |
| A | A61 | A61K2039/55577 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Veterinary biotechnology, specifically poultry vaccine development and disease prevention technologies involving molecular biology, immunology, and agricultural biotechnology
Person of Ordinary Skill (PHOSITA) Profile
A researcher with advanced degrees in veterinary science or molecular biology, familiar with protein engineering, vaccine design, biotechnology platforms, and agricultural disease management strategies
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies like blockchain, IoT, and AI with existing vaccine technologies represents a predictable extension of known approaches to disease management. The core vaccine technology remains fundamentally similar to the source patent's PlcC-NetB fusion protein concept, with additional technological monitoring and delivery systems that are well-established in the field. The variations represent incremental improvements using standard technological integration techniques available to skilled practitioners.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,613 |
|---|---|
| Title | Vaccine for prevention of necrotic enteritis in poultry |
| Assignee(s) | Arizona Board of Regents on Behalf of Arizona State University |